Janet Dillione is Director at CorMedix Inc. (CRMD). They have made 15 open-market trades across 2 companies since 2012, most recently 2026-09-18.
CIK 0001489798
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
9 open-market purchases totalling $406K since 2015, against 6 sales. Across 9 scored buys the stock is down 10.5% at ninety days, and 14.5 points behind the S&P over the same stretch.
9 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| NUAN | 269,279 | $15.1M |
| CRMD | 117,835 | $858K |
| Total | $15.9M |
Shares reported on the most recent Form 4, priced at the 2026-09-18 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 22% | 11% | 44% |
| Avg Move | -4.0% | -9.7% | -10.5% |
| Alpha | -5.3% | -12.9% | -14.5% |
| Scored | 9 | 9 | 9 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRMD | SELL | 2026-01-21 | 2026-01-22 | $6.88 | $69K | +10.3% | -4.8% | +1.8% |
| CRMD | SELL · 10b5-1 | 2025-12-09 | 2025-12-11 | $12.00 | $408K | +0.6% | -40.0% | -43.8% |
| CRMD | SELL · 10b5-1 | 2025-12-02 | 2025-12-04 | $10.00 | $467K | +7.6% | +14.7% | -33.0% |
| CRMD | SELL | 2025-11-24 | 2025-11-26 | $9.93 | $523K | +20.4% | +29.8% | -26.7% |
| CRMD | SELL | 2025-11-14 | 2025-11-18 | $11.42 | $343K | -3.0% | +18.1% | -28.5% |
| CRMD | BUY | 2019-08-16 | 2019-08-16 | $8.19 | $101K | -8.8% | -2.8% | -39.7% |
| CRMD | BUY | 2019-05-15 | 2019-05-17 | $6.74 | $150K | -9.2% | -1.0% | +8.2% |
| CRMD | BUY | 2019-03-18 | 2019-03-20 | $1.67 | $70K | +28.2% | +11.8% | -8.3% |
| CRMD | BUY | 2017-12-12 | 2017-12-14 | $0.48 | $25K | -8.6% | -10.4% | -48.8% |
| CRMD | BUY | 2017-05-15 | 2017-05-17 | $0.48 | $10K | -13.8% | -8.5% | -21.3% |
| CRMD | BUY | 2017-02-14 | 2017-02-15 | $— | — | -7.6% | -20.0% | -78.7% |
| CRMD | BUY | 2016-11-14 | 2016-11-16 | $0.00 | $0 | +3.5% | -4.7% | +27.1% |
| CRMD | BUY | 2016-06-08 | 2016-06-29 | $2.67 | $10K | -10.0% | -25.9% | +33.3% |
| CRMD | BUY | 2015-09-22 | 2016-06-29 | $2.66 | $40K | -10.0% | -25.9% | +33.3% |
| NUAN | SELL | 2013-08-09 | 2013-08-13 | $19.16 | $1.2M | -5.6% | +0.1% | +0.1% |
| NUAN | SELL | 2012-12-14 | 2012-12-18 | $22.00 | $330K | -5.6% | +0.1% | +0.1% |
| NUAN | SELL | 2012-02-14 | 2012-02-16 | $27.40 | $685K | -5.6% | +0.1% | +0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.